rs730880344
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_002294.3(LAMP2):c.128_129dupAT(p.Ala44MetfsTer6) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_002294.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMP2 | NM_002294.3 | c.128_129dupAT | p.Ala44MetfsTer6 | frameshift_variant | Exon 2 of 9 | ENST00000200639.9 | NP_002285.1 | |
LAMP2 | NM_001122606.1 | c.128_129dupAT | p.Ala44MetfsTer6 | frameshift_variant | Exon 2 of 9 | NP_001116078.1 | ||
LAMP2 | NM_013995.2 | c.128_129dupAT | p.Ala44MetfsTer6 | frameshift_variant | Exon 2 of 9 | NP_054701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMP2 | ENST00000200639.9 | c.128_129dupAT | p.Ala44MetfsTer6 | frameshift_variant | Exon 2 of 9 | 1 | NM_002294.3 | ENSP00000200639.4 | ||
LAMP2 | ENST00000434600.6 | c.128_129dupAT | p.Ala44MetfsTer6 | frameshift_variant | Exon 2 of 9 | 1 | ENSP00000408411.2 | |||
LAMP2 | ENST00000371335.4 | c.128_129dupAT | p.Ala44MetfsTer6 | frameshift_variant | Exon 2 of 9 | 1 | ENSP00000360386.4 | |||
LAMP2 | ENST00000706600.1 | c.128_129dupAT | p.Ala44MetfsTer6 | frameshift_variant | Exon 2 of 9 | ENSP00000516464.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 24
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy;C0878677:Danon disease Pathogenic:1
The Ala44fs variant in LAMP2 has not been previously reported in the literature or identified by our laboratory. The Ala44fs variant in LAMP2 is predicted to ca use a frameshift, which alters the protein's amino acid sequence beginning at co don 44 and leads to a premature stop codon six amino acids downstream. This alt eration is then predicted to lead to a truncated or absent protein. Loss of fun ction is an established mechanism of disease for the LAMP2 gene, which makes it highly likely that the Ala44fs variant is pathogenic. Pathogenic variants in LAM P2 have been associated with Danon disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at